Shine-On BioMedical Co.,Ltd. (TPEX:6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
64.50
+0.70 (1.10%)
May 8, 2026, 11:57 AM CST
Market Cap3.21B -2.0%
Revenue (ttm)30.00M
Net Income-110.29M
EPS-2.21
Shares Out49.80M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,000
Average Volume16,058
Open66.20
Previous Close63.80
Day's Range64.50 - 66.20
52-Week Range62.10 - 81.60
Beta-0.13
RSI43.48
Earnings DateMay 14, 2026

About Shine-On BioMedical

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. Shine-On BioMedical Co.,Ltd. was founded in 2011 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements